Congress is considering a House bill that would eliminate a huge incentive for pediatric drug development, slash funding for innovative biomedical research & give RFK Jr. authority to implement his agenda w/o Congressional consent, writes @steveusdin.bsky.social https://www.biocentury.com/article/655338